Ifosfamide-induced Encephalopathy in Patients With Uterine Sarcoma

Taiwanese Journal of Obstetrics and Gynecology

Volumn 49, Issue 1, 2010, Pages 77-80

  Tsai, Shih Hung ^a   Liu, Yung Liang ^a   Chang, Fung Wei ^a   Yu, Mu Hsien ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

encephalopathy; ifosfamide; methylene blue; neurotoxicity; thiamine

Indexed keywords

ALBUMIN; CARBOPLATIN; CISPLATIN; CREATININE; HEMOGLOBIN; IFOSFAMIDE; METHYLENE BLUE; POTASSIUM; SODIUM; THIAMINE; UREA;

AGED; ALERTNESS; AREA UNDER THE CURVE; ARTICLE; BLOOD TRANSFUSION; BRAIN DISEASE; CASE REPORT; COMA; CONFUSION; CREATININE BLOOD LEVEL; DAYTIME SOMNOLENCE; DISORIENTATION; DRUG INDUCED DISEASE; FEMALE; HALLUCINATION; HUMAN; MIXED MULLERIAN TUMOR; MULTIPLE CYCLE TREATMENT; PELVIS TUMOR; PHYSICAL EXAMINATION; SIDE EFFECT; STUPOR; UREA NITROGEN BLOOD LEVEL; UTERUS SARCOMA;

AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; FEMALE; HUMANS; IFOSFAMIDE; METHYLENE BLUE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUROTOXICITY SYNDROMES; SARCOMA; THIAMINE; UTERINE NEOPLASMS; VITAMIN B COMPLEX;

EID: 77953284356     PISSN: 10284559     EISSN: 10284559     Source Type: Journal    
DOI: 10.1016/S1028-4559(10)60014-9     Document Type: Article

References (19)

1. Ajithkumar T., Parkinson C., Shamshad F., and Murray P. Ifosfamide encephalopathy. Clin Oncol (R Coll Radiol) 19 (2007) 108-114
2. Pelgrims J., De Vos F., Van den Brande J., Schrijvers D., Prové A., and Vermorken J.B. Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature. Br J Cancer 82 (2000) 291-294
3. David K.A., and Picus J. Evaluating risk factors for the development of ifosfamide encephalopathy. Am J Clin Oncol 28 (2005) 277-280
4. Bloss J.D., Blessing J.A., Behrens B.C., et al. Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 20 (2002) 1832-1837
5. Sutton G., Blessing J.A., Park R., DiSaia P.J., and Rosenshein N. Ifosfamide treatment of recurrent or metastatic endometrial stromal sarcomas previously unexposed to chemotherapy: a study of the Gynecologic Oncology Group. Obstet Gynecol 87 (1996) 747-750
6. Sutton G., Kauderer J., Carson L.F., Lentz S.S., Whitney C.W., and Gallion H. Gynecologic Oncology Group. Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study. Gynecol Oncol 96 (2005) 630-634
7. Chia C.C., Wu M.P., Huang K.F., and Su C.C. Primary stromal sarcoma of the ovary: a case report. Taiwan J Obstet Gynecol 43 (2004) 110-112
8. Kupfer A., Aeschlimann C., and Cerny T. Methylene blue and the neurotoxic mechanisms of ifosfamide encephalopathy. Eur J Clin Pharmacol 50 (1996) 249-252
9. Rieger C., Fiegl M., Tischer J., Ostermann H., and Schiel X. Incidence and severity of ifosfamide-induced encephalopathy. Anticancer Drugs 15 (2004) 347-350
10. Meanwell C.A., Blake A.E., Latief T.N., et al. Encephalopathy associated with ifosphamide/mesna therapy. Lancet 325 (1985) 406-407
11. Kupfer A., Aeschlimann C., Wermuth B., and Cerny T. Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue. Lancet 343 (1994) 763-764
12. Harpey J.P., Charpentier C., and Coude M. Methylene-blue for riboflavin-unresponsive glutaricaciduria type II. Lancet 327 (1986) 391
13. Hrushesky W.J., Olshefski R., Wood P., Meshnick S., and Eaton J.W. Modifying intracellular redox balance: an approach to improving therapeutic index. Lancet 325 (1985) 565-567
14. Hamadani M., and Awan F. Role of thiamine in managing ifosfamide-induced encephalopathy. J Oncol Pharm Pract 12 (2006) 237-239
15. Clifton II J., and Leikin J.B. Methylene blue. Am J Ther 10 (2003) 289-291
16. Carlson L., Goren M.P., Bush D.A., et al. Toxicity, pharmacokinetics, and in vitro hemodialysis clearance of ifos-famide and metabolites in an anephric pediatric patient with Wilms' tumor. Cancer Chemother Pharmacol 41 (1998) 140-146
17. Kellner O., Dempke W., and Schmoll H.J. Glucose infusions-a possible effective therapeutic option in ifosfamide-induced encephalopathy. Dtsch Med Wochenschr 124 (1999) 1086-1087 [In German]
18. Kasper B., Harter C., Meissner J., Bellos F., Krasniqi F., Ho A.D., and Egerer G. Prophylactic treatment of known ifosfamide-induced encephalopathy for chemotherapy with high-dose ifosfamide?. Support Care Cancer 12 (2004) 205-207
19. Zalupski M., and Baker L.H. Ifosfamide. J Natl Cancer Inst 80 (1988) 556-566